Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-049790)

Filing Details

Accession Number:: 0000950170-25-049790
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-04-02 20:01:10
Reporting Period:: 2025-03-31

Filing Date:: 2025-04-02
Accepted Time:: 2025-04-02 20:01:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286199	K Joseph Belanoff	C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-03-31	35,102	$94.72	2,982,335	No	4	S	Indirect	Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
Common Stock	Disposition	2025-04-01	350	$114.71	2,981,985	No	4	S	Indirect	Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
No	4	S	Indirect	Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.